Effects of elfamycins on elongation factor Tu from Escherichia coli and Staphylococcus aureus
- PMID: 2499247
- PMCID: PMC171486
- DOI: 10.1128/AAC.33.3.322
Effects of elfamycins on elongation factor Tu from Escherichia coli and Staphylococcus aureus
Abstract
Six kirromycin analogs (elfamycins) were compared on the basis of their inhibition of Escherichia coli poly(U)-directed poly(Phe) synthesis and stimulation of elongation factor Tu (EF-Tu)-associated GTPase activity. The elfamycins tested were kirromycin, aurodox, efrotomycin, phenelfamycin A, unphenelfamycin, and L-681,217. The last three lack the pyridone ring present in the other elfamycins. All the elfamycins inhibited poly(U)-dependent poly(Phe) synthesis and stimulated EF-Tu-associated GTPase activity, suggesting that the pyridone ring is not essential for activity. The six elfamycins were also examined in a poly(U)-directed, poly(Phe)-synthesizing system derived from Staphylococcus aureus and had 50% inhibitory concentrations of greater than or equal to 1 mM. When S. aureus ribosomes and E. coli elongation factors were combined in a hybrid poly(Phe)-synthesizing system, aurodox produced essentially complete inhibition of poly(Phe) synthesis with a 50% inhibitory concentration of 0.13 microM. This suggests that the observed high MICs of kirromycin and its congeners in S. aureus reflect a kirromycin-resistant EF-Tu rather than permeability constraints.
Similar articles
-
Comparison of the Tu elongation factors from Staphylococcus aureus and Escherichia coli: possible basis for elfamycin insensitivity.Antimicrob Agents Chemother. 1991 Nov;35(11):2366-70. doi: 10.1128/AAC.35.11.2366. Antimicrob Agents Chemother. 1991. PMID: 1839491 Free PMC article.
-
Synthetic analogs of aurodox and kirromycin active on elongation factor Tu from Escherichia coli.J Antibiot (Tokyo). 1981 Aug;34(8):1039-45. doi: 10.7164/antibiotics.34.1039. J Antibiot (Tokyo). 1981. PMID: 6119303
-
Kirromycin, an inhibitor of protein biosynthesis that acts on elongation factor Tu.Proc Natl Acad Sci U S A. 1974 Dec;71(12):4910-4. doi: 10.1073/pnas.71.12.4910. Proc Natl Acad Sci U S A. 1974. PMID: 4373734 Free PMC article.
-
Elfamycins: inhibitors of elongation factor-Tu.Mol Microbiol. 2017 Oct;106(1):22-34. doi: 10.1111/mmi.13750. Epub 2017 Aug 9. Mol Microbiol. 2017. PMID: 28710887 Free PMC article. Review.
-
Inhibitory mechanisms of antibiotics targeting elongation factor Tu.Curr Protein Pept Sci. 2002 Feb;3(1):121-31. doi: 10.2174/1389203023380855. Curr Protein Pept Sci. 2002. PMID: 12370016 Review.
Cited by
-
A population genomics approach to exploiting the accessory 'resistome' of Escherichia coli.Microb Genom. 2017 Apr 6;3(4):e000108. doi: 10.1099/mgen.0.000108. eCollection 2017 Apr. Microb Genom. 2017. PMID: 28785420 Free PMC article.
-
New Insights into the Mechanism of Action of L-681,217, a Medicinally Promising Polyketide Inhibitor of Bacterial Protein Translation.Biochemistry. 2024 Dec 17;63(24):3336-3347. doi: 10.1021/acs.biochem.4c00541. Epub 2024 Nov 22. Biochemistry. 2024. PMID: 39576948
-
Comparison of the Tu elongation factors from Staphylococcus aureus and Escherichia coli: possible basis for elfamycin insensitivity.Antimicrob Agents Chemother. 1991 Nov;35(11):2366-70. doi: 10.1128/AAC.35.11.2366. Antimicrob Agents Chemother. 1991. PMID: 1839491 Free PMC article.
-
Inhibition of bacterial protein synthesis by elongation-factor-Tu-binding antibiotics MDL 62,879 and efrotomycin.Biochem J. 1992 May 1;283 ( Pt 3)(Pt 3):649-52. doi: 10.1042/bj2830649. Biochem J. 1992. PMID: 1590753 Free PMC article.
-
Identification of an antibiotic from an HTS targeting EF-Tu:tRNA interaction: a prospective topical treatment for MRSA skin infections.Appl Environ Microbiol. 2025 Jan 31;91(1):e0204624. doi: 10.1128/aem.02046-24. Epub 2024 Dec 23. Appl Environ Microbiol. 2025. PMID: 39714192 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical